Showing 5561-5570 of 5771 results for "".
- Trump Says Drug Companies to Unveil Price Cuts in Two Weekshttps://modernod.com/news/trump-says-drug-companies-to-unveil-price-cuts-in-two-weeks/2480129/Major pharmaceutical companies will announce “voluntary, massive” cuts in drug prices in two weeks, President Donald Trump said Wednesday, without providing details, according to a
- Study Examines ImprimisRx’s Dropless Steroid and Antibiotic Intravitreal Injectionhttps://modernod.com/news/study-examines-imprimisrxs-dropless-steroid-and-antibiotic-intravitreal-injection/2480133/Imprimis Pharmaceuticals’ ophthalmology compounding division, ImprimisRx, has announced the findings from a study published in the Journal of Cataract and Refractive Surgery that followed 483 eyes with glaucoma that were undergoing cataract surgery with concomitant trabecular micro
- Cincinnati Eye Institute Launches CEI Vision Partnershttps://modernod.com/news/cincinnati-eye-institute-launches-cei-vision-partners/2480134/Cincinnati Eye Institute (CEI) announced the launch of CEI Vision Partners (CEIVP), a new management services organization made possible with the support of Revelstoke Capital Partners, a Denver-based private equity firm. “For more than 70 years, CEI has been growing as a world-class
- ThromboGenics Enrolls First Patient in Phase 1 Clinical Study Evaluating THR-149 for Treatment of DMEhttps://modernod.com/news/thrombogenics-enrolls-first-patient-in-phase-1-clinical-study-evaluating-thr-149-for-treatment-of-dme/2480139/ThromboGenics NV announced that it has successfully enrolled the first patient in a phase 1 open-label, multicenter, dose escalation study evaluating the safety of THR-149 in the treatment of DME (NCT03511898). THR-149 is a novel plasma kallikrein inhibitor generated using Bicycle Therapeu
- BioTime Further Expands OpRegen Clinical Trial in Dry AMD With the Opening of Two Additional US Siteshttps://modernod.com/news/biotime-further-expands-opregen-clinical-trial-in-dry-amd-with-the-opening-of-two-additional-us-sites/2480141/BioTime announced the expansion of its ongoing phase 1/2a clinical trial for OpRegen, with the addition of two new U.S. sites that are expected to begin treating patients later this quarter. “The addition of these two leading U.S. clinical trial sites is in addition to our current two site
- Tear Film Innovations Completes $8.5 Million Series B Fundinghttps://modernod.com/news/tear-film-innovations-completes-8-5-million-series-b-funding/2480145/Tear Film Innovations announced it has completed a $8.5 million Series B Preferred Stock funding round led by Visionary Ventures Fund LP and Bluestem Capital. “This successful funding round completes the capitalization for our growth strategy. We are currently making key hires to meet the
- Aerie Submits New Drug Application to FDA for Roclatanhttps://modernod.com/news/aerie-submits-new-drug-application-to-fda-for-roclatan/2480148/Aerie Pharmaceuticals announced the submission of its new drug application (NDA) to the FDA for Roclatan (netarsudil/latanoprost ophthalmic solution) .02%/.005%. Roclatan is a once-daily eye drop designed to reduce IOP in patients with glaucoma or ocular hypertension. It is a fixed dose combinati
- Telescope Implant for End-State Macular Degeneration Now on the Federal Supply Schedule and Available at VA Hospitalshttps://modernod.com/news/telescope-implant-for-end-state-macular-degeneration-now-on-the-federal-supply-schedule-and-available-at-va-hospitals/2480149/VisionCare announced that MellingMedical will distribute the Implantable Miniature Telescope (by Dr. Isaac Lipshitz) to Department of Veteran’s Affairs hospitals, military hospitals, and other federal government healthcare facilities in the United States. MellingMedical provides medical su
- First Series C-Round Closing for Medical Device Company Implandata Ophthalmic Productshttps://modernod.com/news/first-series-c-round-closing-for-medical-device-company-implandata-ophthalmic-products/2480150/Ophthalmic medical device company Implandata Ophthalmic Products announced that the company accomplished a first closing of its Series C funding round. The company was able to raise a “mid-single digit million Euro” amount from a strategic and several institutional and private investo
- American Academy of Optometry Launches Academy Online: An Online CE Platformhttps://modernod.com/news/american-academy-of-optometry-launches-academy-online-an-online-ce-platform/2480153/The American Academy of Optometry has announced the launch of a new online CE and resource platform, Academy Online. Users can find a collection of session recordings from past annual meetings as well as distance learning credits. This initiative is aimed at assisting optometrists and vision scie